jili fortune koi
Ujjain (Madhya Pradesh): To protest against Home Minister Amit Shah’s alleged objectionable remarks about Dr Babasaheb Ambedkar, the Congress party workers held a rally at Tower Square on Tuesday. Chanting slogans like ‘Amit Shah, resign’ and ‘Congress will not allow anyone to dishonour Babasaheb,’ the party members marched on foot through the streets, holding photos of Babasaheb. A memorandum addressed to the President of India was submitted that mentioned that the Congress party is protesting against the inappropriate comments made about Babasaheb and demanding Shah’s resignation and apology. The President was urged to dismiss him from the Cabinet. Before the rally, flowers were offered at the statue of Dr Bhimrao Ambedkar at Tower Square. During the event, All India Congress Committee secretary Sanjay Dutt said that the party remains steadfast in its commitment to the legacy of Dr Bhimrao Ambedkar and the Constitution drafted under his leadership. He emphasised that the party is fighting a political and legal battle to ensure that the rights guaranteed by the Constitution are not violated by the ruling government. Former minister Sajjan Singh Verma said that Home Minister Amit Shah used the Parliament as a platform to insult Dr Ambedkar. Shah made derogatory comments about him, and both he and the BJP have undermined affirmative action and reservation rights granted to Scheduled Castes and Scheduled Tribes, along with the constitutional framework. MLA Mahesh Parmar stated that Shah's comments targeting Dr Ambedkar have hurt the sentiments of millions of Indians and called for his immediate dismissal from the position of Home Minister. City Congress Committee president Mukesh Bhati, MLA Dinesh Jain Boss and former MLAs Dilip Gurjar, Murli Morwal, Dr Batuk Shankar Joshi, District Congress in-charge Chandar Singh Sondhiya, City Congress in-charge Amit Sharma, Raja Chouksey, Leader of Opposition Ravi Rai along with a large number of Congress leaders and workers participated in the event.Does Vacuum Freeze-Dried Food Have Nutritional Changes?Irish mixed martial artist Conor McGregor, known as "The Notorious," is no stranger to headlines. From his astronomical earnings and lavish lifestyle to his family life and legal controversies, McGregor remains a polarising figure. Recently, a civil court in Dublin ordered him to pay $250,000 after losing a sexual assault case, further adding to his already controversial legacy. Conor McGregor was ordered to pay over $250,000 in damages after a Dublin High Court jury ruled in favour of Nikita Hand, who accused the UFC star of sexual assault during an incident in 2018. Hand claimed McGregor "brutally raped and battered" her in a Dublin hotel penthouse, leaving her fearing for her life, according to E! News . The report goes on to say that McGregor denied the allegations, asserting that the encounter was consensual and describing the interaction as "vigorous but mutual." The jury, however, sided with Hand, awarding damages for assault. McGregor expressed disappointment with the verdict, stating that critical evidence had been excluded from the case. This is not McGregor's first encounter with sexual assault allegations . In 2023, he was accused of assaulting a woman at an NBA Finals game, but insufficient evidence prevented the case from moving forward. According to People , McGregor has been in a long-term relationship with Dee Devlin since 2008. The couple, engaged since 2020, share four children: Conor Jr., Croía, Rían, and their youngest, Mack. McGregor frequently shares glimpses of his family life on social media, showing a softer side to his often brash public persona. Devlin, who has stood by McGregor through numerous controversies, was seen leaving the courtroom in tears after the verdict, as reported by The Sun . As one of the wealthiest athletes in the world, McGregor's net worth is estimated to range from $200 million to $650 million, depending on sources. His fortune stems primarily from fighting, with his 2017 boxing match against Floyd Mayweather earning him around $130 million. Beyond sports, McGregor has lucrative business ventures , including his whiskey brand, Proper No. Twelve, which was sold in 2021 for a reported $500 million. He has since launched a stout brand, Forged Irish Stout, and owns Dublin's Black Forge Inn. Known for his extravagant spending, McGregor's purchases include luxury cars, designer watches, and multi-million-dollar properties. McGregor made history as the first UFC fighter to hold titles in two weight classes simultaneously. His matches have broken numerous pay-per-view records, with his 2018 fight against Khabib Nurmagomedov garnering 2.4 million buys. Recently, McGregor ventured into acting, starring alongside Jake Gyllenhaal in the film Roadhouse . He claimed to be the highest-paid debut actor in history, surpassing Dwayne "The Rock" Johnson's earnings for The Scorpion King , per The Sun . Although McGregor has not competed in the UFC since 2021 due to a leg injury, he has hinted at a return in 2025. Despite his legal troubles, McGregor remains a global icon in sports and entertainment, with fans eagerly awaiting his next move—whether in the octagon, on screen, or through his entrepreneurial ventures.
Health In Tech Announces Closing of Initial Public OfferingNoodles and wine are the secret ingredients for a strange new twist in China's doping sagaNEW YORK , Dec. 24, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Quanterix Corporation (NASDAQ: QTRX) resulting from allegations that Quanterix may have issued materially misleading business information to the investing public. So What: If you purchased Quanterix securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=31441 call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. What is this about: On November 12, 2024 , after market hours, Quanterix filed a current report on Form 8-K with the SEC. In this current report, the Company announced that on " November 11, 2024 , the Audit Committee of the Board of Directors of the Company, based on the recommendation of the Company's management and after discussion with the Company's independent registered public accounting firm, Ernst & Young LLP ("EY"), concluded that the Company's previously issued audited consolidated financial statements as of December 31, 2023 and 2022 and for each of the three years in the period ended December 31, 2023 , and its unaudited consolidated financial statements for the quarterly and year-to-date (as applicable) periods ended March 31, 2022 , June 30, 2022 , September 30, 2022 , March 31, 2023 , June 30, 2023 , September 30, 2023 , March 31, 2024 , and June 30, 2024 (collectively, the "Non-Reliance Periods"), should no longer be relied upon." On this news, Quanterix's stock price fell $2.77 per share, or 18.3%, to close at $12.40 per share on November 13, 2024 . Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm , on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/ . Attorney Advertising. Prior results do not guarantee a similar outcome. Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 case@rosenlegal.com www.rosenlegal.com View original content to download multimedia: https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-quanterix-corporation-investors-to-inquire-about-securities-class-action-investigation--qtrx-302338948.html SOURCE THE ROSEN LAW FIRM, P. A.
As TikTok bill steams forward, online influencers put on their lobbying hats to visit WashingtonBowling Green earns 87-62 win over Aquinas
In a bid to facilitate the IT sector, the Pakistan Telecommunication Authority (PTA) has allowed freelancers to register their virtual private network (VPN) using mobile numbers. “To facilitate the legitimate, secure and uninterrupted operations of VPN by freelancers who don’t have static IP addresses, the facility to register VPN against mobile number has been introduced by Pakistan Telecommunication Authority (PTA),” read a statement released by PTA on Saturday. “The step is aimed to further simplify the VPN registration process for facilitation of the IT industry,” the authority said, adding that over 31,000 VPNs have been registered by PTA. According to the authority, freelancers can register their mobile number with PTA for “usage of VPNs on mobile data connection at https://ipregistration.pta.gov.pk”. Freelancers would need to provide their details including computerised national identity card (CNIC), company registration details and taxpayer status to register their VPNs. A few days ago, the government decided not to ban VPNs, as the law ministry said the government did not have the legal authority to impose such a ban under the Electronic Crimes Act (PECA) 2016. Earlier, PTA warned its users to register their VPNs by Nov 30, after which unregistered connections would be blocked. The interior ministry had earlier requested a ban, citing concerns about the use of VPNs by terrorists and access to pornographic content. However, the law ministry clarified that PECA allows the blocking of specific online content. Pakistan has a record of curbing online access in response to political turmoil, banning social media sites or simply temporarily shutting down the internet altogether. Days ago, Sajjad Mustafa Syed, chairman of Pakistan Software Houses Association (P@SHA), said that Pakistan’s information technology sector suffers losses of more than $1 million per hour due to internet shutdown in the country. “To achieve the government’s envisaged target of $15 billion, IT exports are linked with market access, infrastructure stability, accommodative taxation policy as well as skilled human resources,” said P@SHA chairman. Syed said that 99% of firms/ companies reported that their services were disrupted and 90% reported losses.Türkiye’s role in the new Syria
Iran advances to fourth place globally in intangible cultural heritage rankings
Best Buy's Growth Hinges On Computing And Services As Q3 Approaches: AnalystFormer pharma exec was allegedly part of $38M insider trading scheme, feds sayFederal appeals court upholds law requiring sale or ban of TikTok in the US A federal appeals court panel on Friday unanimously upheld a law that could lead to a ban on TikTok as soon as next month, handing a resounding defeat to the popular social media platform as it fights for its survival in the U.S. The U.S. Court of Appeals for the District of Columbia Circuit ruled that the law - which requires TikTok to break ties with its China-based parent company ByteDance or be banned by mid-January — is constitutional, rebuffing TikTok’s challenge that the statute ran afoul of the First Amendment and unfairly targeted the platform. TikTok and ByteDance — another plaintiff in the lawsuit — are expected to appeal to the Supreme Court. Executive of Tyler Perry Studios dies when plane he was piloting crashes in Florida ATLANTA (AP) — The president of Atlanta-based Tyler Perry Studios has died when the small plane he was piloting crashed on Florida’s Gulf Coast. The studio confirmed on Saturday that Steve Mensch, its 62-year-old president and general manager, had died Friday. The crash happened in Homosassa, about 60 miles north of Tampa. Photos from the scene show the plane having come to rest upside down on a road. Mensch helped advocate for Georgia’s film tax credit of more than $1 billion a year. Perry hired Mensch to run his namesake studio in 2016. Mensch died as Perry released his war drama, “The Six Triple Eight." The film was shot at the Atlanta studio. US added a strong 227,000 jobs in November in bounce-back from October slowdown WASHINGTON (AP) — America’s job market rebounded in November, adding 227,000 workers in a solid recovery from the previous month, when the effects of strikes and hurricanes had sharply diminished employers’ payrolls. Last month’s hiring growth was up considerably from a meager gain of 36,000 jobs in October. The government also revised up its estimate of job growth in September and October by a combined 56,000. Friday’s report also showed that the unemployment rate ticked up from 4.1% in October to a still-low 4.2%. The November data provided the latest evidence that the U.S. job market remains durable even though it has lost significant momentum from the 2021-2023 hiring boom, when the economy was rebounding from the pandemic recession. Stock market today: Wall Street hits more records following a just-right jobs report NEW YORK (AP) — U.S. stocks rose to records after data suggested the job market remains solid enough to keep the economy going, but not so strong that it raises immediate worries about inflation. The S&P 500 climbed 0.2%, just enough top the all-time high set on Wednesday, as it closed a third straight winning week in what looks to be one of its best years since the 2000 dot-com bust. The Dow Jones Industrial Average dipped 0.3%, while the Nasdaq composite climbed 0.8% to set its own record. Treasury yields eased after the jobs report showed stronger hiring than expected but also an uptick in the unemployment rate. Killing of UnitedHealthcare CEO spotlights complex challenge companies face in protecting top brass NEW YORK (AP) — In an era when online anger and social tensions are increasingly directed at the businesses consumers count on, Meta last year spent $24.4 million to surround CEO Mark Zuckerberg with security. But the fatal shooting this week of UnitedHealthcare CEO Brian Thompson while walking alone on a New York City sidewalk has put a spotlight on the widely varied approaches companies take to protect their leaders against threats. And experts say the task of evaluating threats against executives and taking action to protect them is getting more difficult. One of the primary worries are loners whose rantings online are fed by others who are like-minded. It’s up to corporate security analysts to decide what represents a real threat. Days after gunman killed UnitedHealthcare's CEO, police push to ID him and FBI offers reward NEW YORK (AP) — Nearly four days after the shooting of UnitedHealthcare CEO Brian Thompson, police still do not know the gunman’s name or whereabouts or have a motive for the killing. But they have made some progress in their investigation into Wednesday's killing of the leader of the largest U.S. health insurer, including that the gunman likely left New York City on a bus soon after fleeing the scene. The also found that the gunman left something behind: a backpack that was discovered in Central Park. Police are working with the FBI, which on Friday night announced a $50,000 reward for information leading to an arrest and conviction. USDA orders nationwide testing of milk for bird flu to halt the virus The U.S. government has ordered testing of the nation’s milk supply for bird flu to better monitor the spread of the virus in dairy cows. The Agriculture Department on Friday said raw or unpasteurized milk from dairy farms and processors nationwide must be tested on request starting Dec. 16. Testing will begin in six states — California, Colorado, Michigan, Mississippi, Oregon and Pennsylvania. The move is aimed at eliminating the virus, which has infected more than 700 dairy herds in 15 states. Words on ammo in CEO shooting echo common phrase on insurer tactics: Delay, deny, defend A message left at the scene of an insurance executive’s fatal shooting echoes a phrase commonly used to describe insurer tactics to avoid paying claims. The words “deny,” “defend” and “depose” were written on the ammunition used to kill UnitedHealthcare's CEO. That's according to two officials who spoke to The Associated Press on condition of anonymity Thursday. The words are similar to the phrase “delay, deny, defend.” That's how attorneys describe insurers denying services and payment, and the title of a 2010 book critical of the industry. Police haven’t officially commented on the words. But Thompson’s shooting and the messages on the ammunition have sparked outrage on social media and elsewhere, reflecting frustration Americans have over the cost and complexity of getting care. Michigan Democrats move to protect reproductive health data before GOP takes control of House LANSING, Mich. (AP) — Democrats in Michigan are pressing to pass reproductive health care legislation before the party loses its majority with the new legislative session next year. A bill to protect digital reproductive health data including data logged on menstrual cycle tracking apps is a Democratic priority as lawmakers meet this month. Democratic women and supporters of the legislation say they are acting with new urgency before President-elect Donald Trump takes office because they don't believe his campaign promise to leave abortion to the states. The rush is also a reaction to Republicans taking control of the state House in January. Democrats kept control of the state Senate in the November election. Japan's Nippon Steel sets sights on a growing overseas market in its bid to acquire US Steel KASHIMA, Japan (AP) — The signs at Nippon Steel read: “The world through steel,” underlining why Japan’s top steelmaker is pursuing its $15 billion bid to acquire U.S. Steel. Japan's domestic market isn't growing, so Nippon Steel has its eyes on India, Southeast Asia and the United States, where populations are still growing. Nippon Steel gave reporters a tour of one of its plants in Japan on Friday. The bid for U.S. Steet is opposed by President-elect Donald Trump, President Joe Biden and American steelworkers. If the deal goes through, U.S. Steel will keep its name and its headquarters in Pittsburgh, Pennsylvania, but become subsidiary of Nippon Steel.THOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE Amgen
Azad Jammu and Kashmir (AJK) President Barrister Sultan Mahmood Chaudhry and Prime Minister Chaudhry Anwarul Haq while paying eulogizing tributes to the Father of Nation, Quaid-i-Azam Muhammad Ali Jinnah on his 148th birthday, being celebrated on Wednesday, have said that there was no better way to pay tribute to the great leader than following his golden principles of unity, faith and discipline MIRPUR (AJK ) , (UrduPoint / Point - 24th Dec, 2024) ( ) President Barrister Sultan Mahmood Chaudhry and Chaudhry Anwarul Haq while paying eulogizing tributes to the Father of Nation, Quaid-i-Azam on his 148th birthday, being celebrated on Wednesday, have said that there was no better way to pay tribute to the great leader than following his principles of , faith and discipline. In their messages issued separately on Tuesday, on the eve of the birth anniversary of Father of the Nation, they said that Quaid-i-Azam was the great leader, who changed the course of history. The President said that Jinnah led a relentless struggle that culminated successfully in the shape of - a free homeland for of the sub continent where they live with peace, dignity and absolute freedom. “It was Quaid-i-Azam’s dynamic leadership that turned Allama Iqbal’s dream into a reality,” he added. Barrister Chaudhry said that Quaid-e-Azam was a great leader, great jurist and history maker, adding that he enlightened the of the subcontinent with the two-nation theory that led to the creation of . That is why he declared Kashmir as the jugular vein of ,” he said, adding that Quaid-i-Azam openly supported the freedom movement of Kashmiris and made great efforts to resolve the Kashmir problem. Meanwhile, PM Chaudhry Anwar ul Haq said that Quaid-i-Azam not only changed the history but also the geography of the subcontinent. “Quaid-i-Azam not only defended the identity of as a separate nation, but also turned the dream of a separate homeland for the of the subcontinent into a political reality,” he said. The PM said that the great leader’s motto of commitment, honesty and discipline serves as a guiding principle for the nation. He said that Jinnah declared Kashmir as a jugular vein of and always supported the Kashmiri people. “Quaid-i-Azam was the most popular, highly revered and respected leader amongst the Kashmiri people,” he said. The premier also paid rich tributes to the Kashmiri people for raising their voice against ’s illegal and forcible occupation, saying that the day is not far when the Kashmiri people will get rid of illegal occupation and become part of . APP/ahr/378
China's top leaders are set to discuss GDP growth target, stimulus measures amid economic worries
Trump vows to pardon January 6 defendants on day one
The streets of Damascus are uncharacteristically empty on Saturday night, Zaina Shahla, a 42-year-old journalist living in the centre of the Syrian capital, tells the BBC. After a "normal" morning, she said the streets were filled with people trying to stock up on supplies as reports emerged of rebel fighters heading for the city from both north and south. Now, everyone seems to have gone home - the uncertainty of the situation creating a "sense of fear" among residents. "We are afraid because we really don't know what's going to happen," Ms Shahla said. "Nobody wants to see fighting in Damascus." She added: "Everything is ambiguous and nothing is clear for anyone." Her sentiments are echoed by Rim Turkmani, director of the Syria Conflict Research Programme at the London School of Economics. Her sister in Damascus told her that shops are closing, supplies are running low and ATMs are out of cash, she said. "No one knows what's happening," Ms Turkmani told the BBC. Damascus has not seen the same degree of violence in Syria's decade-long civil war, creating a sense of stability among some of its residents, Ms Shahla said. "If any change is going to happen, it won't be easy." But reports suggest a turning tide is already sweeping through the city's suburbs as rebel fighters led by opposition group Hayat Tahrir al-Sham (HTS) make sweeping territorial gains from the north of the country. An unnamed US official told the BBC's US partner, CBS News, that Damascus appears to be "falling suburb by suburb to the rebels". The rebels themselves claim to have "encircled" the city. Video footage appeared to show a statue of President Bashar al-Assad's late father, Hafez al-Assad, being torn down by protesters in the southern suburb of Jaramana. Syria's state news agency claimed "sleeper cells" were publishing clips on social media from public areas of Damascus to suggest they had taken control of them "with the aim of spreading chaos among citizens". The Syrian government meanwhile denied rumours that Assad had fled the city. Moreover, the interior minister has said there was a "very strong" military cordon around the capital. But government forces have notably failed to provide any such defence in the cities, towns and villages that have fallen to rebel factions. Rebel forces led by the Islamist group Hayat Tahrir al-Sham (HTS) have made a lightning advance over the past fortnight after launching a surprise offensive, capturing the north-western cities of Aleppo and Hama before continuing south and entering parts of the strategically important city of Homs. Their progress has sparked an uprising by allied rebels in the southern region of Daraa, who have taken control of parts of the region. The UN has said it is withdrawing "non-critical" staff from Syria amid the evolving situation. HTS has pledged to protect international organisations operating in the country. The UN envoy to Syria has called for an orderly transition of power, as well as "urgent political talks" to implement a Security Council resolution that seeks a negotiated transition between the Syrian government and opposition. Speaking in Doha on Saturday, Geir Pedersen said representatives of Iran, Russia, Turkey, the US, France, the UK, Germany and the EU had expressed their support for a diplomatic resolution. Damascus's residents have differing views about a rebel takeover, Ms Shahla said, but are bracing themselves for the possibility of armed conflict on their doorstep. Her family have remained throughout Syria's civil war, and have not considered fleeing - until now. While they are not planning on leaving yet, she said, "if things escalate in a dramatic way or a dangerous way, maybe we will think about it". Additional reporting by Jake LaphamLAS VEGAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“ Hyperscale Data ” or the “ Company ”), announced that it was notified today by the NYSE American that due to the Company’s disclosure in its Form 10-Q filed for the fiscal period ended September 30, 2024, which reported stockholders’ equity of approximately $2.2 million, it no longer meets the requirement that it must have no less than $6 million or more in stockholders’ equity pursuant to the listing standard set forth under Section 1003(a)(ii) and (iii) of the NYSE American Company Guide (the “ Listing Standards ”) because the Company has reported losses from continuing operations and/or net losses in five of its most recent fiscal years ended December 31, 2023. Under the applicable NYSE American listing rules, the Company must by January 17, 2025 submit a compliance plan that demonstrates how it intends to regain compliance with the Listing Standards within 18 months of the receipt of the notice, or June 18, 2026. The Company intends to develop and submit to the NYSE American such a plan. If the NYSE American does not accept the plan, or if the Company does not make progress consistent with the plan during the plan period, the NYSE American will initiate delisting procedures. If the NYSE American accepts the plan the Company will be subject to periodic reviews including quarterly monitoring for compliance with the plan. During this period, the Company's common stock will continue to be listed on the NYSE American and trade as usual subject to compliance with other NYSE American listing requirements. The Company is confident that it will be able to submit a plan acceptable to the NYSE American within the requisite period and further that it will promptly be able to demonstrate that it has regained compliance with the Listing Standards. For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data’s public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov. About Hyperscale Data, Inc. Hyperscale Data is transitioning from a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact to becoming solely an owner and operator of data centers to support high performance computing services. Through its wholly and majority-owned subsidiaries and strategic investments, Hyperscale Data owns and operates a data center at which it mines digital assets and offers colocation and hosting services for the emerging artificial intelligence ecosystems and other industries. It also provides, through its wholly owned subsidiary, Ault Capital Group, Inc., mission-critical products that support a diverse range of industries, including an artificial intelligence software platform, social gaming platform, equipment rental services, defense/aerospace, industrial, automotive, medical/biopharma and hotel operations. In addition, Hyperscale Data is actively engaged in private credit and structured finance through a licensed lending subsidiary. Hyperscale Data’s headquarters are located at 11411 Southern Highlands Parkway, Suite 240, Las Vegas, NV 89141. Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at www.hyperscaledata.com . Hyperscale Data Investor Contact: IR@hyperscaledata.com or 1-888-753-2235
DURANGO, Colo., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Rocky Mountain Chocolate Factory Inc. RMCF (the "Company", "we", or "RMCF"), an international franchisor and producer of premium chocolates and other confectionery products, including gourmet caramel apples, is pleased to announce the appointments of Melvin Keating and Al Harper to the Company's Board of Directors, replacing Starlette B. Johnson and Charlson Arnold, effective November 26, 2024. "We'd like to thank both Starlette and Charles for serving on the Board," stated Jeff Geygan, Interim CEO of RMCF. "At the same time, we are delighted to welcome Mel and Al as the newest members of our Board. Their knowledge and experience will bring great value as we look to return Rocky Mountain Chocolate Factory to sustained growth and profitability." Mr. Keating brings extensive experience in corporate leadership, investment advisory, and board service, having served on nearly 20 public company boards throughout his career including directorship for SPS Commerce, Vitamin Shoppe, Tower Jazz Semiconductor, and Crown Crafts, among others. He has held various leadership positions including President and CEO of Alliance Semiconductor Corp., where he successfully executed a complex corporate restructuring, and also served as a Strategy Consultant for Warburg Pincus Equity Partners. He currently serves as a director of Agilysys, Inc. Mr. Harper is a seasoned entrepreneur and leader with expertise spanning industries such as transportation, real estate, and entertainment. As the Owner and President of American Heritage Railways, Inc., he oversees operations for its subsidiaries including the Durango & Silverton Narrow Gauge Railroad and the Great Smoky Mountains Railroad. Mr. Harper is also one of the largest shareholders of RMCF, having recently purchased approximately one million shares of the Company (13% of common shares outstanding). About Rocky Mountain Chocolate Factory, Inc. Rocky Mountain Chocolate Factory, Inc. is an international franchiser of premium chocolate and confection stores, and a producer of an extensive line of premium chocolates and other confectionery products, including gourmet caramel apples. Headquartered in Durango, Colorado, Rocky Mountain Chocolate Factory is ranked among Entrepreneur's Franchise 500 ® and Franchise Times' Franchise 400 ® for 2024. The Company and its franchisees and licensees operate nearly 260 Rocky Mountain Chocolate stores across the United States, with several international locations. The Company's common stock is listed on the Nasdaq Global Market under the symbol "RMCF." Investor Contact Sean Mansouri, CFA Elevate IR 720-330-2829 RMCF@elevate-ir.com © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.THOUSAND OAKS, Calif. , Dec. 2, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday , Dec. 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, Jay Bradner , executive vice president of Research and Development and chief scientific officer at Amgen, and Susan Sweeney , executive vice president of Obesity and Related Conditions at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME. For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn , Instagram , TikTok , YouTube and Threads . Amgen Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla ® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2024-global-healthcare-conference-302319891.html SOURCE Amgen
Thetis Lake Park was briefly closed by West Shore RCMP on Tuesday (Dec. 24) after a report was received of a person with a firearm in the area. Visitors were turned away from the park by police from 10.30 a.m., while they investigated. Police on the scene confirmed to Goldstream News Gazette they had been looking for a person with a firearm, and were satisfied there was no threat to the public. The park was open again for visitors after 11 a.m. "The park is reopened now with no public safety concerns," said the RCMP in a social media post. "Enjoy the day everyone and thanks for your patience as we worked to ensure the park was safe."My baby daughter had a crooked smile — it was actually a fatal brain tumor
Türkiye’s role in the new SyriaWith rookie QB Penix showing poise in starting debut, the Falcons again control their playoff hopesAP Business SummaryBrief at 3:50 p.m. EST{ "@context": "https://schema.org", "@type": "NewsArticle", "dateCreated": "2024-12-07T22:26:37+02:00", "datePublished": "2024-12-07T22:26:37+02:00", "dateModified": "2024-12-07T22:26:35+02:00", "url": "https://www.newtimes.co.rw/article/22427/news/rwanda/former-mp-fidele-mitsindo-passes-on-aged-58", "headline": "Former MP Fidele Mitsindo passes on aged 58", "description": "Former Member of Parliament Fidele Mitsindo has passed away at the age of 58, The New Times has learned. According to a family source, Mitsindo passed...", "keywords": "", "inLanguage": "en", "mainEntityOfPage":{ "@type": "WebPage", "@id": "https://www.newtimes.co.rw/article/22427/news/rwanda/former-mp-fidele-mitsindo-passes-on-aged-58" }, "thumbnailUrl": "https://www.newtimes.co.rw/thenewtimes/uploads/images/2024/12/07/65860.jpg", "image": { "@type": "ImageObject", "url": "https://www.newtimes.co.rw/thenewtimes/uploads/images/2024/12/07/65860.jpg" }, "articleBody": "Former Member of Parliament Fidele Mitsindo has passed away at the age of 58, The New Times has learned. According to a family source, Mitsindo passed on at Rwanda Military Hospital on Friday, December 6. ALSO READ: The journey of the Rwandan parliament The family has announced plans to commemorate his life with a memorial evening on Monday, December 9, followed by his burial on Tuesday, December 10. Mitsindo served as an MP for several years, starting in 2006 and was a member of the Parliamentary Committee on Security and Territorial Integrity. He was also a prominent figure in the Rwanda Patriotic Front (RPF) political party. ALSO READ: What to know about the Rwandan Senate and its mandate Before his tenure in Parliament, Mitsindo held several key administrative roles, including Bourgmester (Mayor) of Giciye Commune (now part of Nyabihu District—and Prefect of Gisenyi Prefecture in the post-genocide period.", "author": { "@type": "Person", "name": "Hudson Kuteesa" }, "publisher": { "@type": "Organization", "name": "The New Times", "url": "https://www.newtimes.co.rw/", "sameAs": ["https://www.facebook.com/TheNewTimesRwanda/","https://twitter.com/NewTimesRwanda","https://www.youtube.com/channel/UCuZbZj6DF9zWXpdZVceDZkg"], "logo": { "@type": "ImageObject", "url": "/theme_newtimes/images/logo.png", "width": 270, "height": 57 } }, "copyrightHolder": { "@type": "Organization", "name": "The New Times", "url": "https://www.newtimes.co.rw/" } }
Syrian insurgents reach the capital's suburbs. Worried residents flee and stock up on supplies BEIRUT (AP) — Insurgents’ stunning march across Syria is gaining speed with news that they have reached the suburbs of the capital of Damascus. The government on Saturday was forced to deny rumors that President Bashar Assad had fled the country. The rebels’ moves around Damascus were reported by an opposition war monitor and a rebel commander. They came after the Syrian army withdrew from much of southern part of the country, leaving more areas, including two provincial capitals, under the control of opposition fighters. The advances in the past week were among the largest in recent years by opposition factions. The factions are by a group that has its origins in al-Qaida and is considered a terrorist organization by the U.S. and the United Nations. An archbishop's knock formally restores Notre Dame to life as winds howl and heads of state look on PARIS (AP) — France’s iconic Notre Dame Cathedral has formally reopened its doors for the first time since a devastating fire nearly destroyed the 861-year-old landmark in 2019. The five-year restoration is widely seen as a boost for French President Emmanuel Macron, who championed the ambitious timeline, and brings a welcome respite from his domestic political woes. World leaders, dignitaries, and worshippers gathered on Saturday evening for the celebrations under the cathedral's soaring arches. The celebration was attended by 1,500 dignitaries, including President-elect Donald Trump, Britain’s Prince William, and Ukrainian President Volodymyr Zelenskyy. For Catholics, Notre Dame’s rector said the cathedral “carries the enveloping presence of the Virgin Mary, a maternal and embracing presence.′′ Trump is welcomed by Macron to Paris with presidential pomp and joined by Zelenskyy for their talks PARIS (AP) — French President Emmanuel Macron has welcomed Donald Trump to Paris with a full a dose of presidential pomp. And they held a hastically-arranged meeting with Ukraine’s Volodymyr Zelenskyy on a day that's mixing pageantry with attention to pressing global problems. The president-elect's visit to France is part of a global a celebration of the reopening of Notre Dame Cathedral five years after a devastating fire. Macron and other European leaders are trying to win Trump’s favor and persuade him to maintain support for Ukraine in its defense against Russia’s invasion. Trump isn't back in office but he's already pushing his agenda and negotiating with world leaders NEW YORK (AP) — Donald Trump is making threats, traveling abroad, and negotiating with world leaders. He has more than a month-and-a-half to go before he’s sworn in for a second term. But the president-elect is already moving aggressively to not only fill his Cabinet and outline policy goals, but also to try to achieve his priorities. In recent days, Trump has threatened to impose a 25% tariff on goods from Canada and Mexico, two of the country’s largest trading partners. That led to emergency calls and a visit. And he's warned of “ALL HELL TO PAY” if Hamas doesn't release the hostages still being held captive in Gaza. South Korea's president avoids an impeachment attempt over short-lived martial law SEOUL, South Korea (AP) — South Korea’s embattled President Yoon Suk Yeol has avoided an opposition-led attempt to impeach him over his short-lived imposition of martial law. Most of Yoon's ruling party lawmakers boycotted a parliamentary vote Saturday to deny a two-thirds majority needed to suspend his presidential powers. The scrapping of the motion is expected to intensify protests calling for Yoon’s ouster and deepen political chaos in South Korea. A survey suggests a majority of South Koreans support the president’s impeachment. Yoon’s martial law declaration drew criticism from his own ruling conservative People Power Party. But the party also apparently fears losing the presidency to liberals. Days after gunman killed UnitedHealthcare's CEO, police push to ID him and FBI offers reward NEW YORK (AP) — Nearly four days after the shooting of UnitedHealthcare CEO Brian Thompson, police still do not know the gunman’s name or whereabouts or have a motive for the killing. But they have made some progress in their investigation into Wednesday's killing of the leader of the largest U.S. health insurer, including that the gunman likely left New York City on a bus soon after fleeing the scene. The also found that the gunman left something behind: a backpack that was discovered in Central Park. Police are working with the FBI, which on Friday night announced a $50,000 reward for information leading to an arrest and conviction. UnitedHealthcare CEO's shooting opens a door for many to vent frustrations over insurance The fatal shooting of UnitedHealthcare's CEO has opened the door for many people to vent their frustrations and anger over the insurance industry. The feelings of exasperation, anger, resentment, and helplessness toward insurers aren’t new. But the shooting and the headlines around it have unleashed a new wave of patients sharing such sentiments and personal stories of interactions with insurance companies. Conversations at dinner tables, office water coolers, social gatherings and on social media have pivoted to the topic. Many say they hope the new amplified voices can bring about change for companies often accused of valuing profits over people. 100-year-old Pearl Harbor survivor recalls confusion and chaos during Japanese bombing 83 years ago PEARL HARBOR, Hawaii (AP) — The bombing of Pearl Harbor 83 years ago launched the United States into World War II. Two survivors are planning to return to the Hawaii military base on Saturday for a remembrance ceremony on the attack's anniversary. They are each over 100 years old. They will join active-duty troops, veterans and members of the public for a remembrance ceremony hosted by the Navy and the National Park Service. A third survivor was planning to join them but had to cancel due to health issues. The bombing killed more than 2,300 U.S. servicemen. An explosion destroys an apartment block in a Dutch city, killing at least 3 and injuring others THE HAGUE, Netherlands (AP) — An explosion and fire has rocked a neighborhood in the Dutch city of The Hague, killing three people and injuring other people and destroying several apartments. The cause of the disaster is unclear. Emergency authorities said four people were rescued from the rubble and taken to the hospital. The mayor said rescuers were no longer looking for survivors but for eventual bodies, but could not specify how many people might still be unaccounted for. Residents of the northeastern neighborhood of Mariahoeve in The Hague heard a huge bang and screams before dawn. Dutch authorities have deployed a specialized urban search and rescue team to find victims. How 'Mufasa' rose with Aaron Pierre and Blue Ivy's voices along with new Lin-Manuel Miranda music SAN DIEGO (AP) — When Aaron Pierre was cast as Mufasa, the weight of following in the late James Earl Jones’ legendary footsteps was enough to rattle any actor. But instead of letting the pressure roar too loudly, he harnessed his nerves to breathe fresh life into his young lion character. Pierre found parallels between himself and his character while filming his leading role in “Mufasa: The Lion King,” which opens in theaters Dec. 20. He took the reigns as the new voice of Mufasa after Jones played the iconic King Mufasa in both the 1994 and 2019 versions of Disney’s “The Lion King.” The prequel offers a fresh exploration into Mufasa’s origin story.What happens when 'The Simpsons' join 'Monday Night Football'? Find out during Bengals-Cowboys